Safran Stock Gains On FY25 Profit, Dividend Hike, Positive FY26 View; FY28 Outlook Upgrade

Safran reported a sharp turnaround in FY2025 with consolidated net income (Group share) of €7.18bn versus a €667m loss a year earlier and EPS of €17.17 (vs. -€1.60). Adjusted net income rose to €3.17bn (+3%) with adjusted EPS €7.60 and adjusted recurring operating income €5.20bn (+26.2%), while consolidated revenue climbed 12.5% to €31.19bn (adjusted €31.329bn, +14.7% organically). The board proposed a €3.35 dividend (+16%) and will continue a €5bn buyback; guidance for FY2026 calls for low-to-mid-teens revenue growth (ex-SPI) and recurring operating income of €6.1–6.2bn, and FY2028 recurring operating income was raised to €7.0–7.5bn, underpinning the stock’s strong intraday move.

Analysis

Market structure: Safran (SAF.PA / SAFRF) is a clear winner — organic adjusted revenue +14.8% and adjusted recurring operating margin +150bps imply stronger aftermarket pricing power and improving OEM delivery cadence. Direct beneficiaries include aftermarket-focused suppliers and MRO chains; losers are low-margin sub-tier suppliers and airlines if higher spare-part pricing is passed through. Cross-asset: expect tightening in aerospace credit spreads (positive for IG corporate bonds), modest EUR strength vs USD on continued French corporate outperformance, and a decline in implied equity vol for Safran/peers as guidance reduces uncertainty.

Risk assessment: Tail risks include tariff escalation, a failed Safran Passenger Innovations carve‑out, a cyclical airline demand shock, or large warranty/technical reserve charges — any of which could erase the 7.18bn headline profit. Immediate (days) risk is a re‑rating and profit-taking after the 7% pop; short-term (weeks) risks center on AGM (May 21) details and buyback execution; long-term (2026–28) execution risk is meeting the raised 2028 recurring operating income target of €7.0–7.5bn. Hidden dependency: ~offset between reported net income (7.18bn) and adjusted net (3.17bn) suggests one-offs/non-cash items that deserve forensic review.

Trade implications: Favor a tactical long in SAF.PA (or ADR SAFRF) sized 2–4% of equity portfolio with entry 320–340 EUR, target 400–420 EUR (18–27% upside) within 6–12 months, stop-loss 300 EUR or if FY26 guidance misses midpoint. Pair trade: long SAF.PA vs short RR.L (Rolls‑Royce) 1:1 notional for relative aftermarket exposure; expect outperformance if Safran sustains margin expansion. Options: buy a 9–12 month SAF.PA call spread (buy 360 / sell 460 EUR) to capture upside while limiting premium; sell covered calls after 20–30% move to monetize buyback-driven squeezes.

Key Decisions for Investors

• Establish a 2–4% long position in Safran (SAF.PA or SAFRF) between €320–€340 per share, target €400–€420 (6–12 month horizon), and place a hard stop at €300 or on any miss of FY26 midpoint guidance (~€6.15bn recurring operating income).
• Implement a relative-value pair trade: long SAF.PA vs short Rolls‑Royce (RR.L) equal notional (size 1–2% portfolio) to exploit Safran's stronger aftermarket/margin trajectory; reassess after two quarters or on material guidance updates.
• Buy a 9–12 month SAF.PA call spread (e.g., buy 360 / sell 460 strikes) sized to represent 1% portfolio risk to capture upside while capping premium; roll or unwind if implied vol drops >25% or after buyback announcements exceed €2.5bn executed.
• Take profits / hedge after a 20–30% move higher: sell covered calls or put on a trailing 10–15% notional hedge; do not increase exposure until the May 21 AGM publishes buyback cadence and Safran Passenger Innovations carve‑out details.
• Reduce/avoid exposure to smaller Tier‑2 aerospace suppliers lacking aftermarket revenue (example: select small-cap aero suppliers in Europe) by 50% over next 3 months; reallocate proceeds to aftermarket/MRO names and Safran exposure.